Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_assertion type Assertion NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_head.
- NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_provenance.
- NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_assertion evidence source_evidence_literature NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_provenance.
- NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_assertion SIO_000772 21613820 NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_provenance.
- NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_assertion wasDerivedFrom befree-20150227 NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_provenance.
- NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_assertion wasGeneratedBy ECO_0000203 NP981047.RAYa6ejGUFKkK2o42mjNBj07aLj3PhyVZdNs0X1qqT-bQ130_provenance.